Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study

David Gordon, Peter Kelley, Susanne Heinzel, Peter Cooper, Nikolai Petrovsky

    Research output: Contribution to journal › Article › peer-review

    90 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study'. Together they form a unique fingerprint.

    Immunology and Microbiology

    Pharmacology, Toxicology and Pharmaceutical Science